BPC-157
Also known as: Body Protection Compound 157, PL 14736
The most studied healing peptide — accelerates tissue repair across muscle, tendon, ligament, and gut.
Molecular structure image coming soon
BPC-157 is sold for research purposes only. It is not FDA-approved for human use. Consult a healthcare provider before use.
Overview
BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. It is one of the most researched peptides for tissue regeneration, wound healing, and anti-inflammatory effects. Research has demonstrated accelerated healing of tendons, ligaments, muscles, bones, and the gastrointestinal tract.
Mechanism of Action
BPC-157 promotes angiogenesis (new blood vessel formation), upregulates growth hormone receptors, modulates nitric oxide synthesis, and activates healing-related growth factors including VEGF and EGF. It also exhibits neuroprotective properties via the dopaminergic system.
Use Cases
- ✓Tendon and ligament healing
- ✓Muscle tear recovery
- ✓Gastrointestinal tract repair (leaky gut, IBD, ulcers)
- ✓Post-surgical recovery
- ✓Joint pain and inflammation
- ✓Traumatic brain injury (TBI) neuroprotection
- ✓Bone healing
Research Summary
Over 100 preclinical studies in rodent models show BPC-157 accelerates healing of tendons, ligaments, and GI tissue. It has been demonstrated to heal Achilles tendons, rotator cuff injuries, and intestinal anastomoses at significantly faster rates than controls. No Phase III human clinical trials have been completed as of 2025, though Phase I safety studies suggest a favorable profile.
Typical Dosing
200–500 mcg per day, subcutaneous or intramuscular injection near injury site. Some protocols use oral delivery for GI conditions.
Administration
Research Chemical
BPC-157 is sold for research purposes only. It is not FDA-approved for human use. Consult a healthcare provider before use.
